Avolio, Alfonso Wolfango
 Distribuzione geografica
Continente #
NA - Nord America 6.319
EU - Europa 5.382
AS - Asia 5.135
SA - Sud America 1.007
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 17.990
Nazione #
US - Stati Uniti d'America 6.150
SG - Singapore 2.245
DE - Germania 1.573
CN - Cina 1.430
SE - Svezia 903
BR - Brasile 830
IT - Italia 631
UA - Ucraina 536
FR - Francia 471
VN - Vietnam 463
GB - Regno Unito 303
IE - Irlanda 271
FI - Finlandia 190
PL - Polonia 180
ID - Indonesia 161
IN - India 140
JP - Giappone 139
TR - Turchia 95
CA - Canada 92
RU - Federazione Russa 89
HK - Hong Kong 87
BD - Bangladesh 75
AR - Argentina 68
IQ - Iraq 58
MX - Messico 51
BE - Belgio 43
KR - Corea 41
ZA - Sudafrica 41
ES - Italia 32
IR - Iran 29
AT - Austria 26
EC - Ecuador 26
VE - Venezuela 26
NL - Olanda 25
PK - Pakistan 25
LT - Lituania 22
SA - Arabia Saudita 22
UZ - Uzbekistan 20
MA - Marocco 17
CH - Svizzera 16
KE - Kenya 16
CL - Cile 15
AE - Emirati Arabi Uniti 14
CO - Colombia 14
RO - Romania 14
PH - Filippine 12
TN - Tunisia 12
CZ - Repubblica Ceca 10
EG - Egitto 10
EU - Europa 10
PY - Paraguay 10
TH - Thailandia 10
AU - Australia 8
UY - Uruguay 8
AZ - Azerbaigian 7
BY - Bielorussia 7
CI - Costa d'Avorio 7
DO - Repubblica Dominicana 7
JO - Giordania 7
KZ - Kazakistan 7
MY - Malesia 7
NP - Nepal 7
PE - Perù 7
BG - Bulgaria 6
DK - Danimarca 6
GR - Grecia 5
JM - Giamaica 5
PA - Panama 5
EE - Estonia 4
OM - Oman 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
AO - Angola 3
BH - Bahrain 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
LV - Lettonia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
BN - Brunei Darussalam 2
BO - Bolivia 2
BW - Botswana 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
MU - Mauritius 2
PS - Palestinian Territory 2
QA - Qatar 2
TG - Togo 2
AL - Albania 1
BJ - Benin 1
Totale 17.975
Città #
Singapore 1.080
Chandler 770
Ashburn 721
San Jose 544
Jacksonville 289
Beijing 278
Dublin 263
San Mateo 235
Ann Arbor 177
Munich 165
Nanjing 155
Rome 155
Ho Chi Minh City 153
Jakarta 142
Lauterbourg 140
New York 136
Los Angeles 132
Hanoi 124
Tokyo 123
Wilmington 120
Boston 119
The Dalles 119
Warsaw 113
Hefei 102
Milan 102
Marseille 97
Woodbridge 90
Seattle 84
Frankfurt am Main 83
Mcallen 83
Lawrence 82
Houston 78
Dearborn 77
Hong Kong 72
Nürnberg 72
Bremen 68
Redwood City 68
Chicago 64
Fairfield 64
Nanchang 62
Izmir 60
Helsinki 58
São Paulo 56
Dallas 54
Moscow 54
Shenyang 54
Santa Clara 50
Cattolica 49
Hangzhou 47
Princeton 47
Hebei 42
Buffalo 41
University Park 41
Zhengzhou 41
Brussels 39
Tianjin 37
Lancaster 36
Andover 33
St Louis 32
Kraków 30
London 29
Shanghai 29
Johannesburg 28
Mountain View 28
Augusta 27
Changsha 27
Guangzhou 27
Kunming 27
Nuremberg 27
Turku 26
Atlanta 25
Baghdad 25
Rio de Janeiro 25
Council Bluffs 24
Montréal 24
Seoul 24
Dhaka 23
Pune 23
Toronto 23
Belo Horizonte 22
Da Nang 22
Kent 22
Norwalk 22
Brooklyn 20
Chengdu 20
Jiaxing 19
Paris 19
Curitiba 18
Haiphong 18
Ningbo 18
Fremont 17
Hounslow 17
Kish 17
Detroit 16
Phoenix 16
Boardman 15
Cambridge 15
Orem 15
Tashkent 15
Brasília 14
Totale 9.370
Nome #
Low values of left ventricular ejection time in the post-anhepatic phase may be associated with occurrence of primary graft dysfunction after orthotopic liver transplantation: results of a single-centre case-control study 409
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 350
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 316
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 233
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 220
Duplex Doppler in the postoperative monitoring of liver transplant recipients 205
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 202
Prediction of poor graft function by means of gastric tonometry in patients undergoing liver transplantation 201
Accidental transplantation of a kidney with stones: case report 192
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 188
Liver transplantation in patients with alcoholic liver disease: A retrospective study 186
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 183
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 182
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 181
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 176
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 167
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 166
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 163
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy 159
Lack of predictivity of serum neopterin, soluble interleukin-2 receptor, and serum amyloid A in long-term kidney transplant recipients 159
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 158
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 158
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 157
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 156
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 153
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 152
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 151
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 149
Prediction of 6-month survival after liver transplantation using Cox regression. 148
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 148
A Bayesan methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study. 148
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 147
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 147
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 147
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 146
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 145
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 144
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 144
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 142
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 142
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 141
Is primary nonfunction still a suitable indication for liver retransplantation? 141
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 140
L-GrAFT and EASE scores in liver transplantation. Need for a reciprocal external validation and comparison with other scores 140
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 140
Viscoelastic versus conventional coagulation tests to reduce blood product transfusion in patients undergoing liver transplantation: A systematic review and meta-analysis 138
Pediatric T-tube in adult liver transplantation: Technical refinements of insertion and removal 138
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 137
Model for end-stage liver disease dynamic stratification of survival benefit 136
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 136
Development and validation of a comprehensive model to predict complications after hepatectomy 133
Psychological risk factors for graft rejection among liver transplant recipients 132
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 132
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 131
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 128
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 127
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 127
Availability of a Web and Smartphone Application to Stratify the Risk of of Early Allograft Failure Requiring Liver Retransplantation 126
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 126
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 126
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 125
High-Flow Nasal Cannula Versus Standard Oxygen Therapy After Extubation in Liver Transplantation: A Matched Controlled Study 125
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 125
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 124
Postoperative respiratory failure in liver transplantation: Risk factors and effect on prognosis 124
Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections 124
Reply to Riva et al. Comment on "Gaspari et al. Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios 122
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 122
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 122
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 121
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 121
Intensive Care Unit-Acquired Weakness after Liver Transplantation: Analysis of Seven Cases and a Literature Review 120
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 120
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 116
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 115
Use of O blood group liver donors for nonidentical recipients: does this represent a double penalty for O blood group candidates? 115
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 115
Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios 114
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 114
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 114
Primary difunction after liver trasplantation: donor or recipients fault? 113
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 112
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 109
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 109
Celiac axis compression syndrome in liver transplantation 109
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 109
Should retransplantation still be considered for primary non-function after liver transplantation? 108
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation 108
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. 107
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study 106
Clinical problems of the transplanted kidney 105
Quantification of liver damage and prediction of 1-year survival after liver transplantation by a multifactorial "recovery score" 105
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 105
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 105
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 104
Toward a novel evidence-based definition of early allograft failure in the perspective of liver retransplant. 104
Discrepancy Between Conventional Coagulation Tests and Thromboelastography During the Early Postoperative Phase of Liver Resection in Neoplastic Patients: A Prospective Study Using the New-Generation TEG®6s 103
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 101
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 99
Liver transplantation for fulminant liver failure: a dilemma in therapeutic approach 98
Totale 14.412
Categoria #
all - tutte 70.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021235 0 0 0 0 0 0 0 0 0 0 212 23
2021/20221.377 85 188 32 108 66 52 11 226 60 56 220 273
2022/20232.323 279 300 219 346 139 291 132 185 252 55 100 25
2023/20241.184 48 378 25 159 54 118 82 38 15 54 106 107
2024/20252.573 45 61 199 95 202 113 66 97 414 282 568 431
2025/20265.935 1.008 204 404 768 1.025 303 1.046 289 368 511 9 0
Totale 18.174